Keyphrases
Response to Treatment
100%
Differential Expression
100%
Nuclear factor-κB
100%
Epidermis
100%
RelA
100%
Psoriatic
100%
Etanercept
100%
Tumor Necrosis Factor-α
18%
Keratinocyte Differentiation
18%
Psoriatic Skin
18%
Psoriatic Arthritis
18%
Psoriasis Disease
18%
Transcription Factor
9%
Cellular Processes
9%
Clinical Outcomes
9%
Inflammatory Cytokines
9%
FDA-approved Drugs
9%
Stress Response
9%
Healthy Skin
9%
Psoriasis Pathogenesis
9%
Fusion Protein
9%
Multiple Signaling Pathways
9%
Mechanism of Action
9%
Immunohistochemistry
9%
Transcriptional Activity
9%
Phospho-specific Antibodies
9%
Basal Level
9%
Targeted Agents
9%
TNF Receptor 1 (TNFR1)
9%
Lesional
9%
Recombinant Human Tumor Necrosis Factor
9%
Keratinocyte Proliferation
9%
Serial Biopsy
9%
Non-lesional
9%
Lesional Skin
9%
Normal Epidermis
9%
Epidermal Thickness
9%
Psoriatic Plaque
9%
Biochemistry, Genetics and Molecular Biology
Downregulation
100%
Immunoglobulin Enhancer Binding Protein
100%
Etanercept
100%
Carisoprodol
100%
Tumor Necrosis Factor
18%
Keratinocyte
18%
Transcription Factors
9%
Proinflammatory Cytokine
9%
Upregulation
9%
Tumor Necrosis Factor Receptor
9%
Antibodies
9%
Chimeric Protein
9%
Pharmacology, Toxicology and Pharmaceutical Science
Immunoglobulin Enhancer Binding Protein
100%
Psoriasis
100%
Carisoprodol
100%
Etanercept
100%
Tumor Necrosis Factor
18%
Transcription Factors
9%
Cytokine
9%
Antibodies
9%
Cellular Processes
9%
Tumor Necrosis Factor Receptor
9%
Psoriatic Arthritis
9%
Chimeric Protein
9%
Immunology and Microbiology
Downregulation
100%
Immunoglobulin Enhancer Binding Protein
100%
Etanercept
100%
Tumor Necrosis Factor
18%
Transcription Factors
9%
Upregulation
9%
Proinflammatory Cytokine
9%
Keratinocyte
9%
Tumor Necrosis Factor Receptor
9%
Psoriatic Arthritis
9%
Antibodies
9%
Keratinocyte Proliferation
9%
Neuroscience
Immunoglobulin Enhancer Binding Protein
100%
Etanercept
100%
Carisoprodol
100%
Necrosis
18%
Keratinocyte
18%
Transcription Factors
9%
Antibodies
9%
Proinflammatory Cytokine
9%
Immunohistochemistry
9%
Chimeric Protein
9%
Tumor Necrosis Factor Receptor
9%